Melissa in the Morning: Cancer Drug Breakthrough

An investigational pancreatic cancer drug is making headlines because recently published study results showed patients survived an average of 13.2 months after starting treatment, compared to 6.7 months for those receiving standard chemotherapy. Dr. Richard Frank is chief of cancer research at Norwalk Hospital and has been involved with this research.Dr. Frank has also recently published three pancreatic cancer study results:Blood test shows early if pancreatic cancer chemo is effectiveKetogenic diet during treatment shows promise in pancreatic cancerPancreatic cancer screenings may benefit people with diabetes